Psychedelic Drug DOI Identifies Neuron to Reduce Anxiety in TIFR Study
• Researchers at TIFR have identified a specific neuron in the ventral hippocampus that, when activated, can alleviate anxiety in rodents.
• The study used the synthetic psychedelic drug DOI to target and trace the PV-positive neuron responsible for reducing anxiety without hallucinations.
• This discovery could lead to more targeted treatments and the development of psychedelic-inspired medications for treatment-resistant mental health conditions.
• The research team collaborated with multiple institutions, including Cornell, Yale, and Columbia universities, to validate their findings.
© Copyright 2025. All Rights Reserved by MedPath